Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valenti

Showing results (331-340 of 358) with videos related to

Pageof 36
Sort By:
Nature Metabolism|February 1, 2022
PSD3 downregulation confers protection against fatty liver diseaseRosellina M Mancina, Kavitha Sasidharan, Anna Lindblom, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Ebiomedicine|November 9, 2025
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohortsRicardo Conde, Rubén Gil-Redondo, Maider Bizkarguenaga, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
The Journal of Clinical Investigation|October 1, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Pageof 36

Showing results (331-340 of 358) with videos related to

Sort By:
Pageof 36
Nature Metabolism|February 1, 2022
PSD3 downregulation confers protection against fatty liver diseaseRosellina M Mancina, Kavitha Sasidharan, Anna Lindblom, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Ebiomedicine|November 9, 2025
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohortsRicardo Conde, Rubén Gil-Redondo, Maider Bizkarguenaga, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
The Journal of Clinical Investigation|October 1, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Pageof 36